Successful re-administration of lenalidomide after lenalidomide-induced pulmonary alveolar hemorrhage in a patient with refractory myeloma

被引：1

作者：

Sakai, Mizu ^{[1
]}

Kubota, Tetsuya ^{[1
]}

Takaoka, Masato ^{[1
]}

Tsukuda, Tsukie ^{[1
]}

Arakawa, Yu ^{[1
]}

Anabuki, Kazuki ^{[1
]}

Ikezoe, Takayuki ^{[1
]}

Togitani, Kazuto ^{[1
]}

Yokoyama, Akihito ^{[1
]}

机构：

[1] Kochi Univ, Dept Hematol & Resp Med, Kochi Med Sch, Nankoku, Kochi 7838505, Japan

来源：

ANNALS OF HEMATOLOGY | 2015年 / 94卷 / 05期

关键词：

PLUS DEXAMETHASONE; MULTIPLE-MYELOMA;

D O I：

10.1007/s00277-014-2260-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：891 / 892

页数：2

共 27 条

[21] Successful re-administration of Pazopanib in a patient with metastatic renal cell carcinoma and a history of Pazopanib-induced nephrotic syndrome: a case report
Jeon, So-Yeon
Lee, Na-Ri
Yim, Chang-Yeol
BMC NEPHROLOGY, 2019, 20 (1)
[22] Successful Re-administration of Atezolizumab for a Non-small-cell Lung Cancer Patient after Cardiac Tamponade Development as a Manifestation of Pseudo-progression Induced by Combination Treatment with Atezolizumab and Cytotoxic Chemotherapy
Nakashima, Koki
Demura, Yoshiki
Sato, Masayuki
Fujii, Yuya
Igarashi, Kazunari
Ishizuka, Tamotsu
INTERNAL MEDICINE, 2021, 60 (18) : 3009 - 3013
[23] Patient-Reported Outcomes in the Phase 3 CARTITUDE-4 Study of Ciltacabtagene Autoleucel Vs Standard of Care in Patients With Lenalidomide-Refractory Multiple Myeloma After 1-3 Lines of Therapy
Weisel, Katja
Mina, Roberto
Mylin, Anne
Yokoyama, Hisayuki
Magen, Hila
Alsdorf, Winfried
Minnema, Monique
Shune, Leyla
Isufi, Iris
Harrison, Simon
Shah, Urvi
Schecter, Jordan
Lendvai, Nikoletta
Gries, Katharine
Katz, Eva
Slaughter, Ana
Lonardi, Carolina
Gilbert, Jane
Li, Quanlin
Deraedt, William
Costa Filho, Octavio
Patel, Nitin
Karlin, Lionel
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S97 - S98
[24] Patient-Reported Outcomes in the Phase 3 CARTITUDE-4 Study of Ciltacabtagene Autoleucel Vs Standard of Care in Patients with Lenalidomide-Refractory Multiple Myeloma after 1-3 Lines of Therapy
Mina, Roberto
Mylin, Anne K.
Yokoyama, Hisayuki
Magen, Hila
Alsdorf, Winfried
Minnema, Monique C.
Shune, Leyla
Isufi, Iris
Harrison, Simon J.
Shah, Urvi A.
Schecter, Jordan M.
Lendvai, Nikoletta
Gries, Katharine S.
Katz, Eva G.
Slaughter, Ana
Lonardi, Carolina
Gilbert, Jane
Li, Quanlin
Deraedt, William
Costa Filho, Octavio
Patel, Nitin
Karlin, Lionel
Weisel, Katja
BLOOD, 2023, 142
[25] Successful treatment of bortezomib-refractory multiple myeloma derived from monoclonal gammopathy of undetermined significance with dose-adjusted lenalidomide therapy in a patient with concomitant end-stage renal disease due to diabetic nephropathy requiring haemodialysis
Kawano, Noriaki
Yokota-Ikeda, Naoko
Minoda, Kunihiro
Hashiguchi, Hiroshi
Yoshida, Shuro
Kuriyama, Takuro
Yamashita, Kiyoshi
Miyazaki, Yoshimasa
Inoue, Sanshiro
Shimao, Yoshiya
Kodama, Keiko
Uezono, Shigehiro
Ueda, Akira
CEN CASE REPORTS, 2014, 3 (01): : 24 - 29
[26] Successful treatment of bortezomib-refractory multiple myeloma derived from monoclonal gammopathy of undetermined significance with dose-adjusted lenalidomide therapy in a patient with concomitant end-stage renal disease due to diabetic nephropathy requiring haemodialysis
Noriaki Kawano
Naoko Yokota-Ikeda
Kunihiro Minoda
Hiroshi Hashiguchi
Shuro Yoshida
Takuro Kuriyama
Kiyoshi Yamashita
Yoshimasa Miyazaki
Sanshiro Inoue
Yoshiya Shimao
Keiko Kodama
Shigehiro Uezono
Akira Ueda
CEN Case Reports, 2014, 3 (1) : 24 - 29
[27] EFFECT OF CILTACABTAGENE AUTOLEUCEL VERSUS STANDARD-OF-CARE ON PATIENT-REPORTED OUTCOMES IN THE CARTITUDE-4 TRIAL OF PATIENTS WITH LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY
Gries, Katharine
Tran, Linh
Appenfeller, Allison
Folkers, Anna
Florendo, Erika
Mina, Roberto
ONCOLOGY NURSING FORUM, 2024, 51 (02)

← 1 2 3 →